Chemical Structure : Serdemetan
CAS No.: 881202-45-5
货号: PC-42840Not For Human Use, Lab Use Only.
Serdemetan (JNJ 26854165) is an anticancer agent that inhibits the function of the E3 ligase HDM2, dose-dependently inhibits proliferation in both wild-type and mutant p53 cell lines with IC50 of 0.25-3 uM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥980 | In stock | |
25 mg | ¥1580 | In stock | |
50 mg | ¥2580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Serdemetan (JNJ 26854165) is an anticancer agent that inhibits the function of the E3 ligase HDM2, dose-dependently inhibits proliferation in both wild-type and mutant p53 cell lines with IC50 of 0.25-3 uM.
Serdemetan (JNJ 26854165) induces p53-mediated apoptosis in acute leukemia cells with wild-type p53, accelerates the proteasome-mediated degradation of p21 and antagonizes the transcriptional induction of p21 by p53, induces S-phase delay and upregulates E2F1 expression in p53 mutant cells.
Serdemetan (JNJ 26854165) demonstrates radiosensitizing activity in vitro and in tumor xenografts.
分子量 | 328.4103 | |
分子式 | C21H20N4 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1,4-Benzenediamine, N1-[2-(1H-indol-3-yl)ethyl]-N4-4-pyridinyl- |
1. Kojima K, et al. Mol Cancer Ther. 2010 Sep;9(9):2545-57.
2. Tabernero J, et al. Clin Cancer Res. 2011 Oct 1;17(19):6313-21.
3. Chargari C, et al. Cancer Lett. 2011 Dec 22;312(2):209-18.
4. Jones RJ, et al. J Pharmacol Exp Ther. 2013 Sep;346(3):381-92.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright